1. Home
  2. OBT vs ENTA Comparison

OBT vs ENTA Comparison

Compare OBT & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orange County Bancorp Inc.

OBT

Orange County Bancorp Inc.

HOLD

Current Price

$33.40

Market Cap

470.6M

Sector

Finance

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.32

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBT
ENTA
Founded
1892
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
470.6M
486.3M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
OBT
ENTA
Price
$33.40
$14.32
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$36.00
$20.40
AVG Volume (30 Days)
70.7K
171.5K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
2.17%
N/A
EPS Growth
N/A
29.93
EPS
2.39
N/A
Revenue
N/A
$102,814,000.00
Revenue This Year
$14.27
$1.94
Revenue Next Year
$7.99
N/A
P/E Ratio
$13.87
N/A
Revenue Growth
N/A
16.48
52 Week Low
$20.97
$4.09
52 Week High
$37.99
$17.15

Technical Indicators

Market Signals
Indicator
OBT
ENTA
Relative Strength Index (RSI) 50.60 56.64
Support Level $23.17 $13.39
Resistance Level $37.99 $15.45
Average True Range (ATR) 1.27 0.83
MACD -0.38 0.08
Stochastic Oscillator 13.08 53.75

Price Performance

Historical Comparison
OBT
ENTA

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: